Cardiac papillary fibroelastoma is a rare benign cardiac tumor that represents less than 10% of all cardiac tumors. Most papillary fibroelastomas are relatively small. Symptoms, if present, are due to flow obstruction or peripheral embolization. The most common sites of origin are aortic and mitral valve surfaces. We present successful surgical resection of a papillary fibroelastoma through the mitral valve which originated from the posterior papillary muscle of the left ventricle.
Introduction
Cardiac papillary fibroelastoma (CPF) is a rare benign cardiac tumor and location in the left ventricle (LV) is noted in 9% of cases [1] . The symptoms, if present, depend on location and size. When diagnosis is established, surgical resection is indicated to establish diagnosis, to prevent complications such peripheral embolization, heart failure and syncoptic episodes.
Case Report
A 73-year-old male referred to our department for the evaluation of a suspected LV mass diagnosed by checkup transthoracic echocardiography (TTE) (Fig. 1a, b) . The patient was asymptomatic. The TTE futures showed a pedunculated mass localized in the LV and originating from the posterior papillary muscle. Intra-operative transesophageal echocardiography (TEE) confirmed the findings from TTE (Fig. 1c, d ). The patient underwent surgical excision of the tumor with standard median sternotomy and cardiopulmonary bypass (CPB).
Ascending aorta and bicaval cannulation was performed and following cardioplegic myocardial arrest approach of the posterior papillary muscle and the tumor was achieved through left atrium (LA) atriotomy and across the mitral valve. Complete resection of the mass with peduncle was performed (Fig.  2a, b) . The patient was weaned from bypass without complications. After uneventful postoperative period, the patient was discharged at home on postoperative day 6. Pathological examination revealed that the mass was a CPF (Fig. 2c, d ). At 3 months years follow-up, she is asymptomatic without neurological residue and the echo showed absence of recurrence.
Discussion
CPF is a rare cardiac tumor and it is the third common primary benign tumor after myxoma and lipoma [2] . Then most frequent site of origin of the CPF is the heart valve and location in the papillary muscle is extremely rare. CPF must therefore be included in the differential diagnosis of heart valve disease, metastatic neoplasm, bacterial endocarditis and endocardiac thrombus.
In the majority of cases, patients with CPF have asymptomatic course. If indeed symptoms are present, these result from the size and mobility of the CPF and its relation to surrounding structures. The most common mechanism of the symptoms is central or peripheral embolization from the tumor or the thrombus which forms on the tumor. Left-sided located CPFs cause neurological complications and are seen in 53% of patients. In addition, acute coronary syndrome, mesenteric ischemia, renal infraction and sudden death have been reported [3] . Right-side location can cause pulmonary embolism.
Nowadays two-and three-dimensional echocardiography is a safe and probably more accurate method of diagnosing cardiac tumors and CPF is no exception [4] . In some instances, visualization can be enhanced by nuclear magnetic resonance imaging (MRI) and it should be considered when TEE is inconclusive. Coronary angiography or CT coronary angiography in patients over 40 years of age is generally required to rule out concomitant coronary artery disease.
When a clinical diagnosis of CPF has been made, surgical resection should be performed for preventing complications from central and peripheral embolization. Surgical excision for treating CPF is gold standard technique and approach of the tumor depends from location in the heart. CPB should be used in all cases and simple excision of the tumor with peduncle is enough in most patients. However, when CPF located in heart valves, replacement or repair should be performed. Surgical 
